Existing risk assessment strategies for predicting mortality in PAH may be improved by the addition of GDF-15 as a biomarker.

Influenza prevention with the cell-based quadrivalent vaccine (QIVc) was superior to the egg-based vaccine (QIVe) during the US 2022–2023 flu season.

Medicaid expansion was associated with a significant reduction in mortality in patients with resectable NSCLC.

Long-term exposure to black carbon is associated with an increased risk for developing asthma and chronic obstructive pulmonary disease.

The United States again earned a D+ grade for preterm birth, according to the 2025 March of Dimes Report Card.

Risk factors for rheumatoid arthritis-related lung diseases include later RA onset, longer RA duration, and previous pulmonary infections.

Nirmatrelvir-ritonavir use was associated with substantially lower rates of COVID-19-related hospitalization among high-risk outpatients.

Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.

Cannabis use is associated with a lower risk for alcohol-associated liver disease in patients with alcohol use disorder.

For those with ALK+ NSCLC who received first-line, next-generation ALK TKI monotherapy, continuing ALK TKI with chemotherapy is linked to better outcomes.

Elexacaftor-tezacaftor-ivacaftor (ETI) may improve bronchial dilatations in adolescents with cystic fibrosis (CF).

Late-onset asthma risk is associated with numerous lifestyle-related metabolites, particularly among women, according to study findings published in The Journal of Allergy and Clinical Immunology.